Researchers track bone health in HIV patients
NCT ID NCT00146094
Summary
This study aimed to understand why people with HIV often develop bone loss (osteopenia and osteoporosis). Researchers followed 44 HIV-positive men for two years, comparing bone density changes between those starting antiretroviral drugs and those not taking them. The goal was to see if the medications played a role in weakening bones.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier de Colmar
Colmar, 68021, France
-
Centre Hospitalier de Mulhouse
Mulhouse, 68070, France
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Conditions
Explore the condition pages connected to this study.